PMDA drug package insert
プロポフォール静注2％50mL「マルイシ」
PMDA Prescription drug · 丸石製薬株式会社 · package insert Aug 17, 2026
Key facts
| Brand names | プロポフォール静注2％50mL「マルイシ」 |
|---|---|
| Nonproprietary names | プロポフォール |
| Companies | 製造販売（輸入）元／丸石製薬株式会社, 提携／B.Braun Melsungen AG（ドイツ） |
| Product type | Prescription drug |
| Therapeutic category | 全身麻酔・鎮静用剤 |
| Therapeutic category codes | 871119 |
| YJ codes | 1119402A5036 |
| Approval numbers | 30100AMX00160 |
| Package insert edition | 第2版 |
| Package insert date | Aug 17, 2026 |
| PMDA document key | 730119_1119402A5036_1 |
| PMDA company code | 730119 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: